SmartMetric (SMME) 10-K 23 Dec 24 2024 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Details
Registrant CIK	0001301991
Fiscal Year End	--06-30
Document Financial Statement Error Correction	false
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Securities Act File Number	000-54853
Entity Registrant Name	SMARTMETRIC, INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	05-0543557
Entity Address, Address Line One	3960 Howard Hughes Parkway
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89109
City Area Code	702
Local Phone Number	990-3687
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float		$ 1,017,459
Entity Common Stock, Shares Outstanding	3,455,157,325
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Auditor Name	Victor Mokuolu, CPA PLLC
Auditor Firm ID	6771
Auditor Location	Houston, Texas

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Current assets
Cash	$ 6,543	$ 20,012
Prepaid expenses and other current assets	6,500	8,667
Total current assets	13,043	28,679
Non-current assets
Patent costs (net of amortization)	38,430	33,750
Due from SBT	1,750	0
Total assets	53,223	62,428
Current liabilities
Accounts payable and accrued expenses	1,432,222	1,233,487
Liability for stock to be issued	12,210	3,080
Deferred Officer's salary	921,602	769,309
Related party interest payable	364,926	305,949
Dividends payable	1,858	1,858
Due to shareholders	52,927	52,927
Convertible note payable, net of discount	227,553	400,660
Convertible interest payable	0	22,200
Shareholder loan	62,751	13,814
Total current liabilities	3,076,049	2,803,284
Total Liabilities	3,076,049	2,803,284
Stockholders' deficit
Common shares	3,455,158	2,222,952
Additional paid-in capital	25,618,556	26,451,292
Accumulated deficit	(32,112,878)	(31,431,438)
Total stockholders' deficit	(3,038,554)	(2,756,583)
Total liabilities and stockholders' deficit	53,223	62,428
Series C Redeemable Convertible Preferred Stock
Current liabilities
Preferred shares	15,728	15,728
Class B Preferred Stock
Stockholders' deficit
Preferred shares	$ 610	$ 610

Consolidated Balance Sheet - Pa

Consolidated Balance Sheet - Parenthetical - $ / shares	Jun. 30, 2024	Jun. 30, 2023
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	1,200,000,000,000	1,200,000,000,000
Common Stock, Shares, Issued	3,455,157,325	2,222,951,485
Common Stock, Shares, Outstanding	3,455,157,325	2,222,951,485
Series C Redeemable Convertible Preferred Stock
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	17,300	17,300
Preferred Stock, Shares Outstanding	17,300	17,300
Class B Preferred Stock
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	610,000	610,000
Preferred Stock, Shares Outstanding	610,000	610,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Class A Preferred Stock
Preferred Stock, Shares Authorized	50,000,000	50,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Condensed Consolidated Statements Of Operations
Revenues	$ 0	$ 0
Expenses
Officer's salary	190,000	190,000
Advertising costs	135,494	207,935
Legal and professional fees	38,857	139,936
General and administrative expenses	203,007	145,999
Research and development	51,767	125,867
Amortization of patent costs	2,591	1,166
Total operating expenses	621,716	810,903
Loss from operations before income taxes	(621,716)	(810,903)
Interest & Financing Expense	(59,725)	(127,800)
Other income (expenses)	0	3,307
Net loss	(681,441)	(935,396)
Preferred stock dividends		0
Net loss available for common stockholders	$ (681,441)	$ (935,396)
Net loss per share, basic and diluted	$ 0	$ 0
Weighted average number of common shares outstanding, basic and diluted	2,699,607,310	710,803,569

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes In Stockholders' (Deficit) - USD ($)	Common Stock	Preferred Stock	Additional Paid-in Capital	Retained Earnings	Total
Total stockholders' deficit	$ 647,887	$ 610	$ 27,546,376	$ (30,496,041)	$ (2,301,170)
Shares, Outstanding	647,886,336	610,000
Shares issued of common stock and warrants for cash	$ 271,525		(8,295)		263,230
Shares issued of common stock and warrants for cash, shares	271,525,383
Shares converted from Preferred C shares to common	$ 14,335		29,415		43,750
Shares converted from Preferred C shares to common, shares	14,335,488
Common shares issued for services	$ 22,750		4,500		27,250
Stock Issued During Period, Shares, Issued for Services	22,750,000
Common shares issued for equity funding conversions	$ 867,658		342,045		1,209,704
Common shares issued for equity funding conversions, shares	867,657,908
Shares issued against Liability	$ 153,993		(1,217,945)		(1,063,951)
Shares issued against liability, Shares	153,992,825
Shares issued against warrants	$ 244,804		(244,804)		0
Shares issued against warrants, Shares	244,803,545
Net loss				(935,396)	(935,396)
Equity, Attributable to Parent, Beginning Balance at Jun. 30, 2022	$ 647,887	$ 610	27,546,376	(30,496,041)	(2,301,170)
Shares, Outstanding, Beginning Balance at Jun. 30, 2022	647,886,336	610,000
Equity, Attributable to Parent, Ending Balance at Jun. 30, 2023	$ 2,222,952	$ 610	26,451,292	(31,431,437)	(2,756,583)
Shares, Outstanding, Ending Balance at Jun. 30, 2023	2,222,951,485	610,000
Total stockholders' deficit	$ 2,222,952	$ 610	26,451,292	(31,431,437)	(2,756,583)
Shares, Outstanding	2,222,951,485	610,000
Shares issued of common stock and warrants for cash	$ 401,167		(243,117)		158,050
Shares issued of common stock and warrants for cash, shares	401,166,665
Common shares issued for equity funding conversions	$ 831,039		(589,619)		241,420
Common shares issued for equity funding conversions, shares	831,039,175
Net loss				(681,441)	(681,441)
Equity, Attributable to Parent, Ending Balance at Jun. 30, 2024	$ 3,455,158	$ 610	25,618,556	(32,112,878)	(3,038,554)
Shares, Outstanding, Ending Balance at Jun. 30, 2024	3,455,157,325	610,000
Total stockholders' deficit	$ 3,455,158	$ 610	$ 25,618,556	$ (32,112,878)	$ (3,038,554)
Shares, Outstanding	3,455,157,325	610,000

Condensed consolidated Statem_3

Condensed consolidated Statements Of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Net Cash Provided by (Used in) Operating Activities
Net loss	$ (681,441)	$ (935,396)
Adjustments to reconcile net loss to net cash used in operating activities
Common stock issued and issuable for services	0	27,250
Amortization of patent costs	2,591	1,166
Amortization of debt discount	0
Gain on PPP forgiveness	0	(20,832)
Changes in assets and liabilities
Increase (Decrease) in prepaid expenses and other current assets	2,167	5,053
Increase in accounts payable and accrued expenses	194,447	180,935
(Decrease) in deferred officer salary	152,293	15,833
Increase in due to shareholder	0	13,814
Decrease in note payable	0	400,660
Increase in Convertible interest payable	(22,200)	14,951
Increase in interest payable	0	(2,625)
Increase in related party interest payable	58,977	52,051
Net cash used in operating activities	(293,166)	(247,140)
CASH FLOWS FROM INVESTING ACTIVITIES
Patent costs	(4,680)	(34,916)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties	48,937	0
Proceeds from sale of common stock	401,167	263,230
Change in stock liability	9,130	0
Conversion of Series C Preferred stock	0	43,750
Change in derivative liability	0	(120,996)
Proceeds from equity funding conversions	0	102,003
Due from SBT	(1,750)	0
Change in convertible note	(173,107)	0
Net cash provided by financing activities	284,377	287,987
NET INCREASE (DECREASE) IN CASH	(13,469)	(5,931)
CASH BEGINNING OF PERIOD	20,012	126,791
END OF PERIOD	6,543	20,012
Non-cash change in stock liability	0	(112,710)
CASH PAID DURING THE PERIOD FOR
Income taxes	0	0
Interest	$ 0	$ 0

NOTE 1 - ORGANIZATION AND BASIS

NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. (the “Company” or “SmartMetric”) was incorporated in the State of Nevada on December 18, 2002. SmartMetric’s main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric Datacard. SmartMetric has completed development of its card along with pre-mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards. Basis of Presentation The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. The Company has adopted June 30 as its fiscal year end. Going Concern As shown in the accompanying consolidated financial statements the Company has sustained recurring losses available to common shareholders of $681,441 and $935,396 for the period ended June 30, 2024 and 2023, respectively, and has an accumulated deficit of $32,112,878 at June 30, 2024 and $31,431,438 at June 30, 2023. The Company will need to raise enough capital or generate revenues to sustain its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date of this filing. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 2 - SUMMARY OF SIGNIFICANT

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Recent Accounting Pronouncements The Company has reviewed all new accounting pronouncements and has concluded that there will be no new pronouncements to adopt. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation. Fair Value of Financial Instruments The carrying amounts reflected in the balance sheets for cash, accounts payable and related party payables approximate the respective fair values due to the short maturities of these items. As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The three levels of the fair value hierarchy are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company at present does not have any Level 2 or Level 3 fair value instruments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Cash The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no cash equivalents at June 30, 2024 and 2023. Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation, and consulting costs. Revenue Recognition The Company has not recognized revenues to date. Therefore, the Company has not yet adopted a revenue recognition policy. Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2024 and 2023, no accrual for uncertain income tax positions is necessary. Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2024 and 2023, 613,935,352 and 16,935,342 dilutive shares were excluded from the calculation of diluted loss per common share, with all dilutive shares being Common stock warrants at June 30, 2024 and 2023.

NOTE 3 - PREPAID EXPENSES

NOTE 3 - PREPAID EXPENSES	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 3 - PREPAID EXPENSES	NOTE 3 PREPAID EXPENSES Prepaid expenses were $6,500 and $8,667 at June 30, 2024 and 2023. All prepaid expenses consist of OTC market fees.

NOTE 4 - COMMITMENTS

NOTE 4 - COMMITMENTS	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 4 - COMMITMENTS	NOTE 4 - COMMITMENTS Lease Agreement The Company’s main office is in Las Vegas, Nevada. Rent expense under all leases for the years ended June 30, 2024 and 2023 was $7,332 and $7,387 respectively. The Company maintains only one office. This office is in Las Vegas, NV and is a month-to-month lease. Related Party Transactions The Company’s Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $62,751 and $13,814 as of June 30, 2024 and 2023, respectively. These advances bear interest at 7% per annum. As of June 30, 2024 and June 30, 2023, the Company has accrued the amounts of $921,602 and $769,309, respectively, as deferred Officer’s salary for the difference between the president’s annual salary and the amounts paid. As a result of these shareholder loans and deferred officer salary, the Company has accrued a balance of $364,926 and $305,949 as interest payable as of June 30, 2024 and 2023. On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, 200,000 shares of Series B Convertible Preferred Stock, we agreed to pay a royalty equal to 5% of gross revenues derived from products sold related to the patents, and we agreed to make certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares. As of June 30, 2024, we had issued the 200,000 shares of Series B Convertible Preferred Stock, and Ms. Hendrick had waived the right to annual payments through June 30, 2024. Our CEO maintains an employment agreement that stipulates a $190,000 annual salary. This agreement is in effect until mutual agreement between its CEO and the Company to terminate.

NOTE 5 - DEBT

NOTE 5 - DEBT	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 5 - DEBT	NOTE 5 - DEBT The Company analyzed the conversion option for derivative accounting consideration under ASC 815, “ Derivatives and Hedging,” Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ - $ -

NOTE 6 - STOCKHOLDERS' DEFICIT

NOTE 6 - STOCKHOLDERS' DEFICIT	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 6 - STOCKHOLDERS' DEFICIT	NOTE 6 STOCKHOLDERS’ DEFICIT Preferred Stock As of June 30, 2024, the Company has 5,000,000 shares of Series B preferred stock, par value $0.001, authorized and 610,000 shares issued and outstanding. Each share of Series B Convertible Preferred Stock has a par value of $0.001, and a stated value equal to $5.00 (“Stated Value”). Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert all or any one (1) share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (“liquidation”), holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. The Company issued 200,000 Series B preferred shares upon its inception in 2004. In October 2015, the Company issued 200,000 Series B preferred shares. On September 11, 2017, the Company issued an additional 210,000 shares of Series B preferred shares to its CEO, Chaya Hendrick, in consideration for grant of exclusive rights to the licensed patent. As of June 30, 2024, the Company has 50,000,000 shares of Class A preferred stock, par value $0.001, authorized and no shares issued and outstanding. Common Stock and Warrants During the three months ended September 30, 2022, the Company issued 257,962,697 shares of common stock, of which 9,750,000 were issued from stock payable, 14,385,488 were converted from 48,125 shares of Preferred C shares, 22,250,000 shares were issued for advertising and promotional services and 221,327,209 shares were issued in conjunction with securities purchase agreements for net proceeds of $330,700. During the three months ended September 30, 2022, the Company sold 0 shares of common stock for net proceeds of $0. The Company issued 4,000,000 shares representing $20,000. During the three months ended December 31, 2022, the Company issued 582,059,999 shares of common stock, of which 4,000,000 were issued for cash and 578,059,999 shares were issued in conjunction with securities purchase agreements. During the three months ended December 31, 2022, the Company sold 0 shares of common stock for net proceeds of $0. During the three months ended March 31, 2023, the Company sold 11,000,000 shares of common stock for net proceeds of $60,000. During the three months that ended September 30, 2023, the Company issued 178,234,886 shares of common stock, of which 20,100,000 were issued for cash and 158,134,886 shares were issued in conjunction with securities purchase agreements. During the three months ended December 31, 2023, the Company sold for cash 260,233,336 shares of common stock for net proceeds of $130,118. During the three months that ended December 31, 2023, the Company issued 421,533,336 shares of common stock, of which 176,900,002 were issued for cash and 161,300,000 shares were issued in conjunction with securities purchase agreements and 83,333,334 shares were issued in conjunction with Regulation A. During the three months ended March 31, 2024, the Company received net proceeds of $21,380 for which 71,333,331 shares are yet to be issued. During the three months that ended March 31, 2024, the Company issued 340,273,852 shares of common stock, of which 120,833,329 were issued for cash and 219,440,523 shares were issued in conjunction with securities purchase agreements. During the three months that ended June 30, 2024, the Company issued 292,163,766 shares of common stock, of which all shares were issued in conjunction with securities purchase agreements with Mast Hill Funding. During the three months that ended March 31, 2023, the Company issued 155,786,846 shares of common stock, of which 11,000,000 were issued for cash, 500,000 shares were issued for services and 144,286,846 shares were issued in conjunction with securities purchase agreements. During the three months ended June 30, 2023, the Company sold for cash 213,333,328 shares of common stock for net proceeds of $116,940. During the three months that ended June 30, 2023, the Company issued 579,255,607 shares of common stock, of which 189,833,325 were issued for cash and 389,422,282 shares were issued in conjunction with securities purchase agreements. During the three months ended September 30, 2022, the Company issued 257,962,697 shares of common stock, of which 9,750,000 were issued from stock payable, 14,385,488 were converted from 48,125 shares of Preferred stock, 22,250,000 shares were issued for advertising and promotional services and 221,327,209 shares were issued in conjunction with securities purchase agreements for net proceeds of $291,410. During the three months ended September 30, 2022, the Company sold 0 shares of common stock for net proceeds of $0. During the three months ended December 31, 2022, the Company issued 582,059,999 shares of common stock, of which 4,000,000 were issued for cash and 578,059,999 shares were issued in conjunction with securities purchase agreements. During the three months ended December 31, 2022, the Company sold 0 shares of common stock for net proceeds of $0. Warrants Outstanding and Exercisable at June 30, 2024: Range of Exercise Prices Number of Warrants Outstanding Weighted- Average Contractual Life Remining in Years Weighted- Average Exercise Price Number Exercisable Weighted- Average Exercise Price Warrants Outstanding and Exercisable at June 30, 2023: $0.10 - $0.20 16,935,352 0.487 $ 0.16 16,935,352 $ 0.498 Warrants Outstanding and Exercisable at June 30, 2024: $0.10 - $0.20 613,935,352 0.412 $ 0.12 613,935,352 $ 0.412 Warrant Activity: As of June 30, 2024 and 2023, the following is a breakdown of the activity: June 30, 2024: Outstanding - beginning of year 16,935,352 Issued 597,000,000 Exercised - Expired - Outstanding - end of year 613,935,352 June 30, 2023: Outstanding - beginning of year 45,997,852 Issued - Exercised - Expired (29,062,500 ) Outstanding - end of year 16,935,352 At June 30, 2024, all of the 613,935,352 warrants are vested, all 613,935,352 warrants expire at various times through December 2025. At June 30, 2023, all 16,935,352 warrants are vested and all 16,935,352 warrants expire at various times through September 2024. Equity Financing On March 5, 2020, the Company entered into an equity financing agreement with GHS Investments, LLC, a Nevada limited liability company (“Investor”). Pursuant to the agreement, the Company agrees the sell to the investor an indeterminate amount of shares of the Company’s common stock, par value $0.001 per share, up to an aggregate price of four million dollars ($4,000,000). Pursuant to the agreement, the Company is required, to within sixty (60) calendar days upon the date of execution of this agreement, use its best efforts to file with the SEC a registration statement or registration statements (as is necessary) on Form S-1, covering the resale of all of the registrable securities, which registration statement(s) shall state that, in accordance with Rule 416 promulgated under the 1933 Act, such registration statement also covers such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock dividends or similar transactions. Pursuant to this equity financing agreement, the Company filed the Registration S-1 on August 6, 2020. Following effectiveness of the Registration Statement, the Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. The Registration Statement has not been deemed effective as of the date of this filing. Concurrently with the execution of the equity financing agreement, the company entered into a convertible promissory note, for the principal balance of $35,000. Per the terms of the convertible note agreement, the Company agrees to pay the investor interest at the rate of ten percent (10%) until it is due on December 5, 2020. The holder shall have the right at any time to convert all or any part of the outstanding and unpaid principal and interest at a fixed conversion price of $0.0175. See note 5. The $35,000 has been recognized as deferred financing costs in current assets on the accompanying Consolidated Balance Sheet, and will be charged against the gross proceeds of each put when received. Although the Company has not as of yet put to GHS, the agreement is in effect for three years, through March, 2023, and as the Company does plan to put to GHS, the Company has determined it is proper for the deferred costs to remain for the length of the agreement. As of June 30, 2022, the Company was in negotiations to have this debt extinguished. As of July 2022, this debt was extinguished.

NOTE 7 - MANDATORY REDEEMABLE C

NOTE 7 - MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 7 - MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	NOTE 7 MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK Issuances of Series C Mandatory Redeemable Convertible Preferred Stock On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company’s Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations, and restrictions, of the Series C Convertible Preferred Stock. On January 14, 2019, the Company filed a Certificate of Designations for a Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 shares, par value 0.001. The Series C Preferred Stock will, with respect to dividend rights and rights upon liquidation, winding-up or dissolution, rank: (a) senior with respect to dividends and right of liquidation with the Company’s common stock, (b) junior with respect to dividends and right of liquidation with respect to the Company’s Series B Preferred Stock; and (c) junior with respect to dividends and right of liquidation to all existing indebtedness of the Company. Series C Preferred Stock will carry an annual ten percent (10%) cumulative dividend, compounded daily, payable solely upon redemption, liquidation, or conversion. The Company will have a right, at any time in the period of 180 days from the date of the issuance, at the Company’s option, to redeem all or any portion of the Series C Preferred Stock at prices ranging from 105% to 130%, based on the passage of time. The number of Series C, mandatory redeemable convertible preferred stock shares issued and outstanding were 17,300 and 17,300, respectively, for June 30, 2024 and June 30, 2023. The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series C Preferred Stock of the Holder (which have not been previously redeemed or converted). With five (5) days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to the total number of shares of Series C Preferred Stock held by such Holder multiplied by the then current Stated Value. All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities The carrying value of the Series C mandatory redeemable convertible preferred stock at June 30, 2024 and 2023 was $15,728 and $15,728, respectively. The estimated fair value of the Series C, mandatory redeemable convertible preferred stock at June 30, 2024 and 2023 was $15,728 and $15,728, respectively. The Company recorded preferred stock dividends of $0 and $0 and accrued dividends payable of $1,858 and $1,858 during fiscal year end 2024 and 2023, respectively.

NOTE 8 - INCOME TAXES

NOTE 8 - INCOME TAXES	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 8 - INCOME TAXES	NOTE 8 INCOME TAXES Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense. At June 30, 2024 and 2023, deferred tax assets consist of the following: 2024 2023 Net operating loss carryforward $ 32,200,747 $ 31,431,438 Warrant issuances - - Deferred officer compensation 921,602 769,309 Other - - Valuation allowance (33,122,349 ) (32,200,747 ) Deferred tax assets, net $ - $ - At June 30, 2024, the Company had a net operating loss carry-forwards in the amount of approximately $32,112,878 million available to offset future taxable income through 2041. These amounts may be carried forward indefinitely, subject to the 80% of taxable income limitation rule. The Company established valuation allowances equal to the full amount of the deferred tax assets due to the uncertainty of the utilization of the operating losses in future periods. A reconciliation of the Company’s effective tax rate as a percentage of income before taxes and federal statutory rate for the period ended June 30, 2024 and 2023 is summarized as follows: 2024 2023 Tax on income before income tax 21.00 % 21.00 % Effect of non-temporary differences (0.01 )% (0.01 )% Effect of prior year items - % - % Effect of temporary differences - % - % Change in valuation allowance (17.34 )% (18.64 )% Effective income tax rate reconciliation, percent 0.00 % 0.00 % The total amount of unrecognized tax benefits can change due to tax examination activities, lapse of applicable statutes of limitations and the recognition and measurement criteria under the guidance related to accounting for uncertainty in income taxes. The Company does not believe any significant increases or decreases will occur within the next twelve months. The Company files income tax returns in the United States (“U.S.”) federal jurisdiction. Generally, the Company is no longer subject to U.S. federal examinations by tax authorities for fiscal years prior to 2020. The Company does not file in any other jurisdiction and remains open for audit for all tax years as the statute of limitations does not begin until the returns are filed. The Company remains subject to U.S. federal examination for tax years ended 2020, 2021, 2022, 2023 and 2024.

NOTE 9 - LITIGATION

NOTE 9 - LITIGATION	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 9 - LITIGATION	NOTE 9 LITIGATION From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. We know of no material, active, pending or threatened proceeding against us or our subsidiaries, nor are we, or any subsidiary, involved as a plaintiff or defendant in any material proceeding or pending litigation.

NOTE 10 - SUBSEQUENT EVENTS

NOTE 10 - SUBSEQUENT EVENTS	12 Months Ended
	Jun. 30, 2024
Notes
NOTE 10 - SUBSEQUENT EVENTS	NOTE 10 SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has reviewed its operations subsequent to June 30, 2024 to the date these financial statements were issued. There have been no subsequent events between June 30, 2024 and December 23, 2024.

NOTE 2 - SUMMARY OF SIGNIFICA_2

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Recent Accounting Pronouncements (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has reviewed all new accounting pronouncements and has concluded that there will be no new pronouncements to adopt.

NOTE 2 - SUMMARY OF SIGNIFICA_3

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fair value of financial instruments (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Fair value of financial instruments	Fair Value of Financial Instruments The carrying amounts reflected in the balance sheets for cash, accounts payable and related party payables approximate the respective fair values due to the short maturities of these items. As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The three levels of the fair value hierarchy are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). The Company at present does not have any Level 2 or Level 3 fair value instruments.

NOTE 2 - SUMMARY OF SIGNIFICA_4

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Use of Estimates (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

NOTE 2 - SUMMARY OF SIGNIFICA_5

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Cash (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Cash	Cash The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company had no cash equivalents at June 30, 2024 and 2023.

NOTE 2 - SUMMARY OF SIGNIFICA_6

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Research and Development (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Research and Development	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation, and consulting costs.

NOTE 2 - SUMMARY OF SIGNIFICA_7

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Revenue Recognition (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Revenue Recognition	Revenue Recognition The Company has not recognized revenues to date. Therefore, the Company has not yet adopted a revenue recognition policy.

NOTE 2 - SUMMARY OF SIGNIFICA_8

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Reclassifications (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Reclassifications	Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

NOTE 2 - SUMMARY OF SIGNIFICA_9

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Uncertainty in Income Taxes (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Uncertainty in Income Taxes	Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2024 and 2023, no accrual for uncertain income tax positions is necessary.

NOTE 2 - SUMMARY OF SIGNIFIC_10

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Loss Per Share of Common Stock (Policies)	12 Months Ended
	Jun. 30, 2024
Policies
Loss Per Share of Common Stock	Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2024 and 2023, 613,935,352 and 16,935,342 dilutive shares were excluded from the calculation of diluted loss per common share, with all dilutive shares being Common stock warrants at June 30, 2024 and 2023.

NOTE 5 - DEBT_ Schedule of Deri

NOTE 5 - DEBT: Schedule of Derivative Liabilities at Fair Value (Tables)	12 Months Ended
	Jun. 30, 2024
Tables/Schedules
Schedule of Derivative Liabilities at Fair Value	Level 1 Level 2 Level 3 Total Derivative liability $ - $ - $ - $ -

NOTE 6 - STOCKHOLDERS' DEFICIT_

NOTE 6 - STOCKHOLDERS' DEFICIT: Schedule of share-based compensation warrant activity (Tables)	12 Months Ended
	Jun. 30, 2024
Tables/Schedules
Schedule of share-based compensation warrant activity	Range of Exercise Prices Number of Warrants Outstanding Weighted- Average Contractual Life Remining in Years Weighted- Average Exercise Price Number Exercisable Weighted- Average Exercise Price Warrants Outstanding and Exercisable at June 30, 2023: $0.10 - $0.20 16,935,352 0.487 $ 0.16 16,935,352 $ 0.498 Warrants Outstanding and Exercisable at June 30, 2024: $0.10 - $0.20 613,935,352 0.412 $ 0.12 613,935,352 $ 0.412

NOTE 6 - STOCKHOLDERS' DEFICI_2

NOTE 6 - STOCKHOLDERS' DEFICIT: Schedule of Nonvested Share Activity (Tables)	12 Months Ended
	Jun. 30, 2024
Tables/Schedules
Schedule of Nonvested Share Activity	June 30, 2024: Outstanding - beginning of year 16,935,352 Issued 597,000,000 Exercised - Expired - Outstanding - end of year 613,935,352 June 30, 2023: Outstanding - beginning of year 45,997,852 Issued - Exercised - Expired (29,062,500 ) Outstanding - end of year 16,935,352

NOTE 8 - INCOME TAXES_ Schedule

NOTE 8 - INCOME TAXES: Schedule of Deferred Tax Assets (Tables)	12 Months Ended
	Jun. 30, 2024
Tables/Schedules
Schedule of Deferred Tax Assets	2024 2023 Net operating loss carryforward $ 32,200,747 $ 31,431,438 Warrant issuances - - Deferred officer compensation 921,602 769,309 Other - - Valuation allowance (33,122,349 ) (32,200,747 ) Deferred tax assets, net $ - $ -

NOTE 8 - INCOME TAXES_ Schedu_2

NOTE 8 - INCOME TAXES: Schedule of effective income tax rate reconciliation (Tables)	12 Months Ended
	Jun. 30, 2024
Tables/Schedules
Schedule of effective income tax rate reconciliation	2024 2023 Tax on income before income tax 21.00 % 21.00 % Effect of non-temporary differences (0.01 )% (0.01 )% Effect of prior year items - % - % Effect of temporary differences - % - % Change in valuation allowance (17.34 )% (18.64 )% Effective income tax rate reconciliation, percent 0.00 % 0.00 %

NOTE 1 - ORGANIZATION AND BAS_2

NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION (Details) - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Details
Net loss	$ 681,441	$ 935,396
Accumulated deficit	$ 32,112,878	$ 31,431,438

NOTE 2 - SUMMARY OF SIGNIFIC_11

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Loss Per Share of Common Stock (Details) - shares	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Details
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	613,935,352	16,935,342

NOTE 3 - PREPAID EXPENSES (Deta

NOTE 3 - PREPAID EXPENSES (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Details
Prepaid Expense	$ 6,500	$ 8,667

NOTE 4 - COMMITMENTS (Details)

NOTE 4 - COMMITMENTS (Details) - USD ($)		3 Months Ended		12 Months Ended
	Sep. 11, 2017	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024
Operating Leases, Rent Expense		$ 7,332	$ 7,387
Shareholder loan		62,751	13,814	$ 62,751
Deferred Compensation Liability, Current and Noncurrent		921,602	769,309	921,602
Interest Payable		$ 364,926	$ 305,949	364,926
Chief Executive Officer
Related Party Transaction, Description of Transaction	from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, 200,000 shares of Series B Convertible Preferred Stock, we agreed to pay a royalty equal to 5% of gross revenues derived from products sold related to the patents, and we agreed to make certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares. As of June 30, 2024, we had issued the 200,000 shares of Series B Convertible Preferred Stock
Annual salary				$ 190,000

NOTE 5 - DEBT_ Schedule of De_2

NOTE 5 - DEBT: Schedule of Derivative Liabilities at Fair Value (Details)	Jun. 30, 2024 USD ($)
Derivative Liability	$ 0
Fair Value, Inputs, Level 1
Derivative Liability	0
Fair Value, Inputs, Level 2
Derivative Liability	0
Fair Value, Inputs, Level 3
Derivative Liability	$ 0

NOTE 6 - STOCKHOLDERS' DEFICIT

NOTE 6 - STOCKHOLDERS' DEFICIT (Details) - USD ($)		1 Months Ended	3 Months Ended								4 Months Ended	12 Months Ended
	Mar. 05, 2020	Oct. 31, 2015	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2022	Jun. 30, 2024	Jun. 30, 2023	Sep. 11, 2023
Stock Issued During Period, Shares, Other								11,000,000	0	0
Stock Issued During Period, Shares, New Issues				340,273,852		178,234,886	579,255,607	155,786,846	421,533,336	257,962,697	582,059,999
Debt Conversion, Converted Instrument, Shares Issued										9,750,000
Conversion of Stock, Shares Converted										14,385,488
Stock Issued During Period, Shares, Issued for Services										22,250,000
Proceeds from sale of common stock												$ 401,167	$ 263,230
Proceeds Received from Shares Yet to be Issued				$ 21,380
Shares Yet to be Issued				71,333,331
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period												0	29,062,500
Convertible Promissory Note
Registration statement description	Company shall have the discretion to deliver puts to GHS and GHS will be obligated to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) based on the investment amount specified in each put notice. The maximum amount that the Company shall be entitled to put to GHS in each put notice shall not exceed two hundred percent (200%) of the average daily trading dollar volume of the Company’s Common Stock during the ten (10) trading days preceding the put, so long as such dollar amount does not exceed $500,000. Pursuant to the Equity Financing Agreement, GHS and its affiliates will not be permitted to purchase and the Company may not put shares of the Company’s Common Stock to GHS that would result in GHS’s beneficial ownership, equaling more than 4.99% of the Company’s outstanding Common Stock. The price of each put share shall be equal to eighty percent (80%) of the Market Price (as defined in the Equity Financing Agreement). Puts may be delivered by the Company to GHS until the earlier of thirty-six (36) months after the effectiveness of the Registration Statement. The Registration Statement has not been deemed effective as of the date of this filing.
Warrant
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares												613,935,352	16,935,352
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period												613,935,352	16,935,352
Common Stock
Stock Issued During Period, Shares, Issued for Services										22,250,000			22,750,000
Shares issued of common stock and warrants for cash, shares					260,233,336		213,333,328					401,166,665	271,525,383
Common shares issued for equity funding conversions, shares			292,163,766									831,039,175	867,657,908
Securities Purchase Agreements
Proceeds from sale of common stock										$ 330,700
Conjunction with Securities Purchase Agreement
Stock Issued During Period, Shares, Other										221,327,209
Debt Conversion, Converted Instrument, Shares Issued				219,440,523		158,134,886	389,422,282	144,286,846	161,300,000		578,059,999
Proceeds from sale of common stock										$ 291,410
Cash
Debt Conversion, Converted Instrument, Shares Issued				120,833,329		20,100,000	189,833,325	11,000,000	176,900,002		4,000,000
Proceeds from sale of common stock							$ 116,940		$ 130,118
Conjunction with Regulation A
Debt Conversion, Converted Instrument, Shares Issued									83,333,334
Services
Debt Conversion, Converted Instrument, Shares Issued								500,000
Class B Preferred Stock
Preferred Stock, Shares Authorized			5,000,000				5,000,000					5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share			$ 0.001				$ 0.001					$ 0.001	$ 0.001
Preferred Stock, Shares Issued			610,000				610,000					610,000	610,000
Preferred Stock, Shares Outstanding			610,000				610,000					610,000	610,000
Series B Preferred Stock
Stock Issued During Period, Shares, Other			200,000
Series B Convertible Preferred Stock
Preferred Stock, Shares Authorized														210,000
Stock Issued During Period, Shares, Other		200,000
Class A Preferred Stock
Preferred Stock, Shares Authorized			50,000,000				50,000,000					50,000,000	50,000,000
Preferred Stock, Par or Stated Value Per Share			$ 0.001				$ 0.001					$ 0.001	$ 0.001
Preferred Stock, Shares Issued			0				0					0	0
Preferred Stock, Shares Outstanding			0				0					0	0
Common Stock | Advertising And Promotional Services
Conversion of Stock, Shares Converted										48,125

NOTE 6 - STOCKHOLDERS' DEFICI_3

NOTE 6 - STOCKHOLDERS' DEFICIT: Schedule of share-based compensation warrant activity (Details) - $ / shares			12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Details
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit	$ 0.1	$ 0.1
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit	$ 0.2	$ 0.2
Number of Warrants Outstanding (in Shares)	613,935,352	16,935,352	613,935,352	16,935,352
Weighted-Average Contractual Life Remaining in Years			4 months 28 days	5 months 25 days
Weighted- Average Exercise Price	$ 0.12	$ 0.16	$ 0.12	$ 0.16
Number Exercisable (in Shares)	613,935,352	16,935,352	613,935,352	16,935,352
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableWarrantsWeightedAverageExercisePrice2	$ 0.412	$ 0.498	$ 0.412	$ 0.498

NOTE 6 - STOCKHOLDERS' DEFICI_4

NOTE 6 - STOCKHOLDERS' DEFICIT: Schedule of Nonvested Share Activity (Details) - shares	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022
Details
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	613,935,352	16,935,352	45,997,852
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted	597,000,000	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	0	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period	0	(29,062,500)

NOTE 7 - MANDATORY REDEEMABLE_2

NOTE 7 - MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details) - USD ($)		3 Months Ended	12 Months Ended
	Jan. 14, 2019	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023
Estimated Fair Value Of Convertible Preferred Stock		$ 15,728	$ 15,728	$ 15,728
Dividends, Preferred Stock			0	0
Dividends payable		$ 1,858	$ 1,858	$ 1,858
Minimum
Preferred Stock, Dividend Rate, Percentage	105%
Maximum
Preferred Stock, Dividend Rate, Percentage	130%
Series C Convertible Preferred Stock
Preferred Stock, Shares Authorized	1,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001
Preferred Stock, Dividend Rate, Percentage	10%
Preferred Stock, Shares Outstanding		17,300	17,300	17,300
Preferred Stock, Shares Issued		17,300	17,300	17,300
Preferred shares convertible average market price rate		71%
Fair value of convertible preferred stock (in Dollars)		$ 15,728	$ 15,728	$ 15,728

NOTE 8 - INCOME TAXES_ Schedu_3

NOTE 8 - INCOME TAXES: Schedule of Deferred Tax Assets (Details) - USD ($)	Jun. 30, 2024	Jun. 30, 2023
Details
Net operating loss carryforward	$ 32,200,747	$ 31,431,438
Warrant issuances	0	0
Deferred officer compensation	921,602	769,309
Other	0	0
Valuation allowance	(33,122,349)	(32,200,747)
Deferred tax assets, net	$ 0	$ 0

NOTE 8 - INCOME TAXES (Details)

NOTE 8 - INCOME TAXES (Details)	12 Months Ended
	Jun. 30, 2024 USD ($)
Details
Operating Loss Carryforwards	$ 32,112,878
Income Tax Examination, Description	The Company remains subject to U.S. federal examination for tax years ended 2020, 2021, 2022, 2023 and 2024

NOTE 8 - INCOME TAXES_ Schedu_4

NOTE 8 - INCOME TAXES: Schedule of effective income tax rate reconciliation (Details)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Details
Tax on income before income tax	21%	21%
Effect of non-temporary differences	(0.01%)	(0.01%)
Effect of prior year items	0%	0%
Effect of temporary differences	0%	0%
Change in valuation allowance	(17.34%)	(18.64%)
Effective income tax rate reconciliation, percent	0%	0%